CN103637188A - Functional food for prevention and treatment of cardio cerebrovascular diseases - Google Patents
Functional food for prevention and treatment of cardio cerebrovascular diseases Download PDFInfo
- Publication number
- CN103637188A CN103637188A CN201310594015.0A CN201310594015A CN103637188A CN 103637188 A CN103637188 A CN 103637188A CN 201310594015 A CN201310594015 A CN 201310594015A CN 103637188 A CN103637188 A CN 103637188A
- Authority
- CN
- China
- Prior art keywords
- parts
- functional food
- prevention
- sea
- wheat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 21
- 235000013376 functional food Nutrition 0.000 title claims abstract description 15
- 230000002265 prevention Effects 0.000 title claims abstract description 14
- 241000209140 Triticum Species 0.000 claims abstract description 25
- 235000021307 Triticum Nutrition 0.000 claims abstract description 25
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 11
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 10
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 10
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 10
- 241000241413 Propolis Species 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 10
- 229940069949 propolis Drugs 0.000 claims abstract description 10
- 235000013339 cereals Nutrition 0.000 claims abstract description 6
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 4
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 22
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 19
- 244000131316 Panax pseudoginseng Species 0.000 claims description 11
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 11
- 244000194101 Ginkgo biloba Species 0.000 claims description 9
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 17
- 235000013305 food Nutrition 0.000 abstract description 7
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 239000009429 Ginkgo biloba extract Substances 0.000 abstract 1
- 235000003143 Panax notoginseng Nutrition 0.000 abstract 1
- 241000180649 Panax notoginseng Species 0.000 abstract 1
- 229940068052 ginkgo biloba extract Drugs 0.000 abstract 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 235000013312 flour Nutrition 0.000 description 8
- 241000219051 Fagopyrum Species 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000011669 selenium Substances 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- -1 phytosterol Natural products 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000201986 Cassia tora Species 0.000 description 2
- 235000014552 Cassia tora Nutrition 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to functional food for prevention and treatment of cardio cerebrovascular diseases, and overcomes the technical problems of side effects and no significant curative effects of the prior art, the functional food contains the following components: by weight, 50-100 parts of color grain wheat, 10-30 parts of oat, 10-30 parts of buckwheat, 8-12 parts of notoginseng, 8-12 parts of ganoderma lucidum spore powder, 10-18 parts of cassia seed, 4-6 parts of a ginkgo biloba extract, 5-8 parts of deep-sea small kelp and 5-10 parts of propolis, and the parts of functional food can be used in the food preparation field.
Description
Technical field
The present invention relates to a kind of food, is a kind of functional food with prevention and treatment cardiovascular and cerebrovascular disease specifically.
Background technology
Cardiovascular and cerebrovascular disease is exactly cardiovascular and cerebrovascular disease general designation.Cardiovascular and cerebrovascular disease has " incidence of disease is high, disability rate is high, the death rate is high, recurrence rate is high, complication many ", the i.e. feature of " four is high by more than ".At present, China's Patients with Cardiovascular/Cerebrovascular Diseases surpasses 2.7 hundred million.China dies from nearly 3,000,000 people of cardiovascular and cerebrovascular disease every year, accounts for 51% of the annual total Death causes of China.The domestic medicament categories for cardiovascular and cerebrovascular disease is various at present, but most products effect or not obvious, or side effect greatly very easily produces injury to human body.
Summary of the invention
The present invention will solve the technical problem that prior art curative effect is remarkable, have side effect, and a kind of functional food with prevention and treatment cardiovascular and cerebrovascular disease is provided.
The technical problem to be solved in the present invention is achieved through the following technical solutions:
There is a brand-new functional food for prevention and treatment cardiovascular and cerebrovascular disease, mainly by each raw material of following weight portion, made: color grain wheat 50-100 part, oat 10-30 part, buckwheat 10-30 part, pseudo-ginseng 8-12 part, lucidum spore powder 8-12 part, cassia seed 10-18 part, ginkgo biloba p.e 4-6 part, deep-sea little sea-tangle 5-8 part, propolis 5-10 part.
Preferably, the component that the present invention contains following weight portion: get purple wheat 40KG, green wheat 30KG, oat 10KG, buckwheat 10KG, pseudo-ginseng 8KG, lucidum spore powder 8KG, cassia seed 10KG, ginkgo biloba p.e 4KG, the little sea-tangle 5KG in deep-sea, propolis 5KG.
For realizing object of the present invention, described color grain wheat flour is at least one in the red wheat flour of coffee, purple wheat flour, blue wheat flour, green wheat flour, brown wheat flour, grey wheat flour, black wheat flour.
The present invention can produce following good effect compared with the prior art: the present invention is that to take color grain wheat (coffee redness, blueness, green, purple, brown, grey, a black) wholemeal be primary raw material, oat, buckwheat, pseudo-ginseng, cassia seed, lucidum spore powder, ginkgo biloba p.e is auxiliary material, the little sea-tangle in deep-sea is spices, the brand-new functional food that propolis is antistaling agent.
Main component of the present invention---color grain wheat whole wheat, except containing than common wheat more vegetable protein, amino acid, thiamine, dietary fiber, vitamin A and microelements of calcium (Ca), iron (Fe), zinc (Zn), selenium (Se), iodine (I), be also rich in other with the anthocyanidin lacking in based food, flavonoids, alkaloid, phytosterol, cardiac glycoside isoreactivity material.Anthocyanidin is a kind of powerful antioxidant, can effectively contain the diseases relevant to free radical such as cancer, heart disease, early ageing, and strengthens in addition the effect of blood vessel elasticity, can prevent the generation of cardiovascular and cerebrovascular disease.Flavonoids is exactly " heart bodyguard ", and he can suppress the generation of low-density lipoprotein, reduces the formation of thrombus, better protects cardiovascular and cerebrovascular to avoid harm.Organic Selenium is exactly " anticancer king ", can effectively remove the various harmful toxins of human body, effectively reduces the generation of lipid peroxide, strengthens the immunity of human body.
Oat, containing elements such as crude protein, starch, fat and phosphorus, iron, calcium, water-soluble dietary fiber is respectively 4.7 times and 7.7 times of wheat and maize; Also containing B family vitamin, niacin, folic acid, pantothenic acid, vitamin E; The amino acid ratio of components of protein is more comprehensive, and 8 necessary seed amino acid content of human body all rank first.Often eat and can prevent and treat the cardiovascular and cerebrovascular disease being caused by high fat of blood, obviously reduce cholesterol, triglycerides, beta lipoprotein in cardiovascular and liver.
Buckwheat, is rich in starch, protein, fat, cellulose, and nutrition balance index 80-92. buckwheats are containing 18 seed amino acids; Fat is maximum with oleic acid and linoleic acid content, accounts for 75% of fatty acid total amount.In addition,, also containing citric acid, oxalic acid and malic acid etc., micro-calcium, phosphorus, iron, copper, zinc and selenium, boron, iodine, nickel, cobalt etc., also containing rutin, flavonoids and chlorophyll etc.Often the edible cholesterol that can effectively reduce human body, plays certain prevention effect to cardiovascular and cerebrovascular diseases, and diabetic is also had to extraordinary hypoglycemic, effect of weight reducing, is current generally acknowledged diabetes and cardiovascular and cerebrovascular patient's good food.
Pseudo-ginseng, has promoting blood circulation to remove blood stasis effect, energy platelet aggregation-against, and antithrombotic forms.Pseudo-ginseng anti-thrombosis function link has comprised platelet aggregation-against, antithrombase and promotion fibrinolysis process.Pseudo-ginseng can be improved the content of CAMP in blood platelet, reduces the synthetic of thromboxane A2, and the active material that suppresses the short platelet aggregations such as Ca++, 5-HT discharges, performance antiplatelet aggregative activity.
Cassia seed, claims again " going back pupil ", contains multivitamin and abundant amino acid, fat, carbohydrate etc., has the functions such as clearing away the liver-fire, wines used as antirheumatic, tonifying kidney and improving eyesight, often drinks cassia-tora tea, can make blood pressure normal, free movement of the bowels, and old eye is not spent.Clinical trial certificate, drinks cassia-tora tea and can clear liver and improve vision, prevent eye-blurred, hypotensive, reducing blood lipid, minimizing cholesterol etc., for preventing and treating coronary heart disease, hypertension has good curative effect.
Lucidum spore powder; there is the effect to blood pressure bidirectional modulation; it is diastole coronary blood flow effectively, improves microcirculation, increases scheming oxygen supply; purify the blood; reduce Blood Cholesterol and neutral fat content, prevent and dissolve the thrombus in blood vessel, stimulate circulation; acute myocardial ischemia is had to protective effect, can reduce the formation of atherosclerotic plaque.For diseases such as coronary heart diseases and angina pectoris, artery sclerosis, hypertension, highs fat of blood, there is good prevention and auxiliary therapeutic action.
Ginkgo biloba p.e can alleviate cholesterolemia, triacylglycerol, the adverse effect of VLDL to human body simultaneously, alleviates blood fat, improves microcirculation, suppresses blood coagulation.
The little sea-tangle in deep-sea, contains calcium, iodine, selenium, fucoidin, sweet mellow wine etc.In < < Compendium of Materia Medica > >, record: " sea-tangle nature and flavor are salty-cold; have soft muscle dissipating bind, dispelling phlegm to stop asthma, can manage it Li Shui, the effects such as lipoid and reducing blood pressure of being dispelled, can control that carbuncle is swollen, place food does not disappear, urine is smooth, cough breathe heavily, the disease such as oedema, hypertension." modern medicine proves, sea-tangle has positive effect in various disease conditions such as prevention of obesity, cardiovascula arteriosclerosis, hypertension, coronary heart disease, thyroid gland enlargements.
Propolis, in the present invention as antistaling agent, has kept biologically active and the effective ingredient of various raw materials to greatest extent.
The present invention all adopts superfine communication technique, and primary raw material does not lose under the prerequisite of going out not changing its physical attribute and active component, is ground into 250-300 orders, has greatly improved nutrient absorption rate, is easier to digest and assimilate, and effect is faster, better.The present invention can be made as and reconstitute pulvis, edible as daily dinner, convenient and swift.
The present invention adopts tens kinds of pure natural raw material, all according to tcm clinical practice " monarch " compatibility theory carry out strict, careful and precise, closely after reasonable compatibility, by strict formula, add various major ingredients and auxiliary material.
The specific embodiment
Below in conjunction with specific embodiment, further describe the present invention, advantage and disadvantage of the present invention will be more clear along with description.But these embodiment are only exemplary, scope of the present invention are not formed to any restriction.It will be understood by those skilled in the art that lower without departing from the spirit and scope of the present invention and can the details of technical solution of the present invention and form be modified or be replaced, but these modifications and replacement all fall within the scope of protection of the present invention.
Embodiment 1
A kind of brand-new functional food with prevention and treatment cardiovascular and cerebrovascular disease, it makes according to the following steps: get purple wheat 40KG, green wheat 30KG, oat 10KG, buckwheat 10KG, pseudo-ginseng 8KG, lucidum spore powder 8KG, cassia seed 10KG, ginkgo biloba p.e 4KG, the little sea-tangle 5KG in deep-sea, propolis 5KG and adopt respectively superfine communication technique, be crushed to 250-300 order, after mixing, make powdery and reconstitute product.
Embodiment 2
A kind of brand-new functional food with prevention and treatment cardiovascular and cerebrovascular disease, it makes according to the following steps: get purple wheat 60KG, green wheat 40KG, oat 15KG, buckwheat 15KG, pseudo-ginseng 12KG, lucidum spore powder 12KG, cassia seed 18KG, ginkgo biloba p.e 8KG, the little sea-tangle 8KG in deep-sea, propolis 8KG and adopt respectively superfine communication technique, be crushed to 250-300 order, after mixing, make powdery and reconstitute product.
Embodiment 3
A kind of brand-new functional food with prevention and treatment cardiovascular and cerebrovascular disease, it makes according to the following steps: get purple wheat 30KG, green wheat 20KG, oat 8KG, buckwheat 8KG, pseudo-ginseng 6KG, lucidum spore powder 6KG, cassia seed 10KG, ginkgo biloba p.e 3KG, the little sea-tangle 4KG in deep-sea, propolis 4KG and adopt respectively superfine communication technique, be crushed to 250-300 order, after mixing, make powdery and reconstitute product.
Test example 1
The functional observation test of the brand-new functional food of the present invention:
One, the object of observation: 60 routine patients are cardiovascular and cerebrovascular disease, the male sex 32 people wherein, women 28 people, 60 years old mean age, all voluntary participation test-meal tests.
Two, eating method and consumption: the health-preserving food that the embodiment of the present invention 3 is prepared, every day 1 time, each oral 30g, takes three months.
Three, model case: grandson XX, female, 70 years old, medical history 10 years, symptom: left side body movement is stiff, angina pectoris.Diagnosis: coronary heart disease, cerebral thrombus.Take health-preserving food of the present invention, every day 1 time, each 30g, taking three months is three courses for the treatment of.Symptom after edible: left side body movement recovers obviously, and angina pectoris disappears substantially.
Four, observed result: take 60 routine patients of the present invention, take after three months, patients with coronary heart disease often has phenomenon substantially to disappear, and thrombus situation is alleviated to some extent, and total effective rate is 90%.
Product of the present invention also can be made into other formulation.
Claims (2)
1. a functional food with prevention and treatment cardiovascular and cerebrovascular disease, is characterized in that the component that contains following weight portion: color grain wheat 50-100 part, oat 10-30 part, buckwheat 10-30 part, pseudo-ginseng 8-12 part, lucidum spore powder 8-12 part, cassia seed 10-18 part, ginkgo biloba p.e 4-6 part, deep-sea little sea-tangle 5-8 part, propolis 5-10 part.
2. the functional food with prevention and treatment cardiovascular and cerebrovascular disease according to claim 1, is characterized in that the component that contains following weight portion: purple wheat 40KG, green wheat 30KG, oat 10KG, buckwheat 10KG, pseudo-ginseng 8KG, lucidum spore powder 8KG, cassia seed 10KG, ginkgo biloba p.e 4KG, the little sea-tangle 5KG in deep-sea, propolis 5KG.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310594015.0A CN103637188A (en) | 2013-11-21 | 2013-11-21 | Functional food for prevention and treatment of cardio cerebrovascular diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310594015.0A CN103637188A (en) | 2013-11-21 | 2013-11-21 | Functional food for prevention and treatment of cardio cerebrovascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103637188A true CN103637188A (en) | 2014-03-19 |
Family
ID=50242595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310594015.0A Pending CN103637188A (en) | 2013-11-21 | 2013-11-21 | Functional food for prevention and treatment of cardio cerebrovascular diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103637188A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103859258A (en) * | 2014-03-31 | 2014-06-18 | 邓林生 | Mixed recuperation food containing ginkgo leaf and shredded kelp and preparation method thereof |
CN104351641A (en) * | 2014-11-12 | 2015-02-18 | 山东农业大学 | Colored-granule waxy wheat mixing powder and preparation method thereof |
CN104872522A (en) * | 2015-06-11 | 2015-09-02 | 山东农业大学 | High-protein purplish glutinous rice wholewheat mixing powder and preparation method thereof |
CN107668716A (en) * | 2017-11-01 | 2018-02-09 | 佛山市三水区敏俊食品有限公司 | A kind of health food of functions of relaxing muscles and tendons and promoting |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374121A (en) * | 2002-03-26 | 2002-10-16 | 刘方明 | Baggod health gingko tea and its prepn |
CN102178734A (en) * | 2011-04-26 | 2011-09-14 | 庞会心 | Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and resisting fatigue |
WO2011146660A1 (en) * | 2010-05-18 | 2011-11-24 | Antioxidant Superfoods, Inc. | Improved health characteristic dulce de leche confection compositions and flavored milk |
CN102813198A (en) * | 2012-08-31 | 2012-12-12 | 威海五谷怡健食品有限公司 | Functional food for preventing hyperlipidemia, hyperglycemia and hypertension of middle aged and elderly people and preparation method thereof |
-
2013
- 2013-11-21 CN CN201310594015.0A patent/CN103637188A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374121A (en) * | 2002-03-26 | 2002-10-16 | 刘方明 | Baggod health gingko tea and its prepn |
WO2011146660A1 (en) * | 2010-05-18 | 2011-11-24 | Antioxidant Superfoods, Inc. | Improved health characteristic dulce de leche confection compositions and flavored milk |
CN102178734A (en) * | 2011-04-26 | 2011-09-14 | 庞会心 | Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and resisting fatigue |
CN102813198A (en) * | 2012-08-31 | 2012-12-12 | 威海五谷怡健食品有限公司 | Functional food for preventing hyperlipidemia, hyperglycemia and hypertension of middle aged and elderly people and preparation method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103859258A (en) * | 2014-03-31 | 2014-06-18 | 邓林生 | Mixed recuperation food containing ginkgo leaf and shredded kelp and preparation method thereof |
CN104351641A (en) * | 2014-11-12 | 2015-02-18 | 山东农业大学 | Colored-granule waxy wheat mixing powder and preparation method thereof |
CN104872522A (en) * | 2015-06-11 | 2015-09-02 | 山东农业大学 | High-protein purplish glutinous rice wholewheat mixing powder and preparation method thereof |
CN107668716A (en) * | 2017-11-01 | 2018-02-09 | 佛山市三水区敏俊食品有限公司 | A kind of health food of functions of relaxing muscles and tendons and promoting |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103054113B (en) | Composite fruit-vegetable juice beverage with blood sugar decreasing effect | |
CN103445103B (en) | Healthcare chickpea nutrition powder with anti-fatigue effect | |
CN103445117B (en) | Healthcare radix puerariae nutrition powder capable of preventing alcoholic liver injury | |
CN102422857A (en) | Celery cookie and processing method thereof | |
CN102178756B (en) | Oral liquid for treating high altitude disease (HAD) and preparation method thereof | |
CN102813198B (en) | Functional food for preventing hyperlipidemia, hyperglycemia and hypertension of middle aged and elderly people and preparation method thereof | |
CN105126067B (en) | A kind of composition of anti-trioxypurine and application thereof | |
CN103860903A (en) | Medicinal liquor capable of reducing blood pressure, blood sugar, and blood fat | |
CN104432036A (en) | Health care nutrition composition capable of relieving asthenopia as well as preparation method and application thereof | |
CN103637188A (en) | Functional food for prevention and treatment of cardio cerebrovascular diseases | |
CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
CN101108227A (en) | Konjak extractive powder capsule | |
CN102293290B (en) | Tea capable of digesting and smoothing intestine and preparation method thereof | |
CN102217664B (en) | Functional food of color wheat for resisting oxidation and aging and preventing cardiocerebral vascular disease | |
CN108208511A (en) | A kind of ginseng pulverate's compound solid beverage and preparation method thereof | |
CN103461906B (en) | Health care radix puerariae nutrition powder capable of resisting fatigue | |
CN108433108A (en) | Six red pigment preparations of one kind and preparation method thereof | |
CN101406644A (en) | Medicament with function for reducing blood sugar | |
CN103005415A (en) | Blood-fat-reducing herbal cuisine gruel and making method thereof | |
CN106666377A (en) | Chenopodium quinoa willd and lophatherum gracile strengthened nutritive rice having various health-care functions and preparation method of chenopodium quinoa willd and lophatherum gracile strengthened nutritive rice | |
CN110447744A (en) | A kind of health care alternative tea and wall cell disruption powder alternative tea | |
CN101642528B (en) | Production process of compound soft ginsengs | |
CN105011309A (en) | Abalone and sea cucumber health-care drink | |
CN110496212A (en) | A kind of Chinese medicine composition and preparation method thereof improving wine poison constitution | |
CN108883145A (en) | A kind of medicament for oral administration applying combined treatment AIDS, tumour outside |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 264205 No. 109 middle Qingdao Road, Weihai District, Shandong Applicant after: Weihai Wugu Jianyi Food Co., Ltd. Address before: 264400 Shandong province Wendeng city boundary stone Zhenkun Kunyu Road No. 58 Applicant before: Weihai Wugu Jianyi Food Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140319 |
|
RJ01 | Rejection of invention patent application after publication |